If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Acquisition

29 Jul 2025 17:10

RNS Number : 0649T
Compagnie de Saint-Gobain
29 July 2025
 

SAINT-GOBAIN reinforcES ITS construction chemicals platform WITH three bolt-on ACQUISITIONsin North america, Italy and peru

 

 

Saint-Gobain reinforces its construction chemicals platform with:

 

· Two acquisitions securing key technologies that it will scale across the Group, Interstar Materials in North America and Isoltech in Italy;

 

· A local acquisition in Peru, Soquimic, enhancing Saint-Gobain's footprint in this high-growth market.

 

Interstar Materials is a leading North American manufacturer of high-performance pigments for all segments of concrete including ready-mix and precast concrete. Established in 1987, it operates two facilities in Canada (Quebec and Alberta) and one in the United States (Illinois). Concrete coloring has become popular amongst architects and contractors, with granular pigments having many advantages over liquid or powder pigments: they yield more vibrant colors, are simple to transport and store, easy to handle without temperature constraints and more environmentally friendly. Interstar will enrich Saint-Gobain's range of solutions for the growing demand in decorative concrete solutions for façade, flooring and architectural elements and benefit from the Group's strong presence in construction chemicals in North America.

 

Isoltech is an Italian manufacturer of additives specialized in cellular concrete technology used in the production of lightweight concrete. Established in 1987, it operates a production facility in Verdellino, northern Italy. Its solutions are widely recognized for their excellent thermal and acoustic insulation, as well as their fire resistance, recyclability, vapor and water permeability. Isoltech serves the ready-mix concrete, precast and screed markets.

 

Soquimic is a leading manufacturer of concrete admixtures in Peru. Established in 2013, the company has two plants located in Lurin, near Lima, and in Arequipa, in southern Peru. This transaction will enrich Saint-Gobain's range of solutions and accelerate its growth in Peru, following the acquisition of Z Aditivos in 2021, offering cement additives, and will complement the offering of Weber tile adhesives and facade renders.

 

Interstar, Isoltech and Soquimic generate revenues of around €25 million. They will benefit from Chryso's expertise, innovation and R&D capabilities to support customers in the development of low-carbon materials and from Saint-Gobain's global geographical footprint to expand their portfolio and value proposition in the market.

 

These acquisitions are in line with Saint-Gobain's strategic plan, "Grow & Impact" which aims to both strengthen the Group's worldwide leadership and accelerate its growth by enriching its range of solutions for light and sustainable construction.

 

About Saint-Gobain

Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufactures and distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonization of construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group, celebrating its 360th anniversary in 2025, remains more committed than ever to its purpose "MAKING THE WORLD A BETTER HOME".

 

€46.6 billion in sales in 2024

More than 161,000 employees, locations in 80 countries

Committed to achieving net zero carbon emissions by 2050

 

For more information about Saint-Gobain, visit www.saint-gobain.com and follow us on X @saintgobain

Analyst/investor relations

Press relations

Vivien Dardel:

+33 1 88 54 29 77

Patricia Marie:

+33 1 88 54 26 83

Floriana Michalowska:

+33 1 88 54 19 09

Laure Bencheikh:

+33 1 88 54 26 38

Alix Sicaud:

+33 1 88 54 38 70

Yanice Biyogo: 

 +33 1 88 54 27 96

James Weston: 

+33 1 88 54 01 24

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQRLMFTMTMTBAA
Date   Source Headline
11th Jan 20197:06 amRNSNew facility
10th Jan 20195:42 pmRNSDisposal
8th Jan 20197:12 amRNSDisposal
18th Dec 20188:48 amRNSAcquisition
30th Nov 20189:24 amRNSCancellation of shares
26th Nov 20188:21 amRNSLaunching of Transformation Program
23rd Nov 20188:23 amRNSDisposal
25th Oct 20185:02 pmRNS3rd Quarter Results
11th Oct 20183:57 pmRNSFinal Terms
10th Oct 20185:49 pmRNSFinal terms
5th Oct 20187:47 amRNSAcquisition
1st Oct 201810:43 amRNSStabilisation Notice - Compagnie de Saint-Gobain
20th Sep 20185:10 pmRNSAcquisition
20th Sep 20184:57 pmRNSFinal Terms
20th Sep 20184:56 pmRNSFinal Terms
12th Sep 20186:15 pmRNSStabilisation Notice - COMPAGNIE DE SAINT-GOBAIN
12th Sep 20185:49 pmRNSIssue of Debt
12th Sep 20188:54 amRNSStabilisation Notice - COMPAGNIE DE SAINT-GOBAIN
24th Aug 20185:21 pmRNSProspectus Supplement
1st Aug 20187:11 amRNSAcquisition
31st Jul 20185:23 pmRNSDivestment
26th Jul 20185:15 pmRNSHalf-year Report
13th Jul 20185:15 pmRNSProspectus
3rd Jul 20189:35 amRNSAcquisition
22nd Jun 20182:34 pmRNSFinal Terms
22nd Jun 20182:33 pmRNSFinal Terms
15th Jun 20188:47 amRNSCancelation of shares
24th May 20182:24 pmRNSFinal Terms
11th May 20187:00 amRNSAcquisition
26th Apr 20184:52 pmRNS1st Quarter Results
17th Apr 20184:58 pmRNSFinal Terms
13th Apr 20187:16 amRNSAcquisition
11th Apr 20185:08 pmRNSAcquisition
28th Mar 20185:02 pmRNSCapex
22nd Mar 20183:14 pmRNSIssue of Debt
19th Mar 20189:04 amRNSAcquisition
13th Mar 20184:57 pmRNSIssue of Debt
2nd Mar 20187:00 amRNSProspectus Supplement
1st Mar 20184:53 pmRNSAcquisition
22nd Feb 20185:04 pmRNS2017 Results
25th Jan 20184:52 pmRNSNew capacity
11th Jan 20185:12 pmRNSAcquisition
20th Dec 20174:50 pmRNSIssue of Debt
19th Dec 20177:27 amRNSAcquisition
6th Dec 20174:49 pmRNSAcquisition
4th Dec 20177:04 amRNSAcquisition
30th Nov 20174:55 pmRNSShares cancellation
24th Nov 20174:51 pmRNSAcquisition
23rd Nov 20176:12 pmRNSDecisions of Board of Directors
26th Oct 20176:08 pmRNSNine-months sales

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.